Low Dose Aspirin for Prevention of Early Pregnancy Loss
Status:
RECRUITING
Trial end date:
2025-07-15
Target enrollment:
Participant gender:
Summary
Preeclampsia is a pregnancy-specific, multisystem disorder affecting 3% to 8% of pregnancies and remains a significant cause of maternal and neonatal morbidity and mortality worldwide.
The World Health Organization estimates that approximately 76,000 maternal deaths annually are attributed to preeclampsia, accounting for 16% of global maternal mortality, with the majority occurring in low- and middle-income countries